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PRE-ECLAMPSIA
Pre-eclampsia, a pregnancy disorder
defined clinically by maternal hypertension
and proteinuria, affects 5–10% of
pregnancies and is a major cause of peri-
natal morbidity and mortality [1].
In healthy pregnancy, placental tissue in-
vades maternal uterine arteries causing
reduced arterial elasticity and promoting
blood supply to the placenta. In early-onset
pre-eclampsia (<34 weeks) this invasion is
inadequate, resulting in stressed placentas
deprived of blood flow and often yielding
growth-restricted fetuses. In late-onset
pre-eclampsia (34 weeks) the condition
is characterized more by defects in mater-
nal cardiovascular health than by inad-
equate placental invasion. In both cases,
the results are a pro-inflammatory mater-
nal immune environment, hypertension
and blood vessel damage in kidney, liver
and brain [2].
The multiple risk factors of pre-eclamp-
sia include poor maternal cardiovascular
health (including hypertension and obes-
ity), presence of risk alleles and lack of ex-
tended sexual exposure of the mother to
the father prior to conception [3].
EVOLUTIONARY PERSPECTIVES
Pre-eclampsia is common only in humans
(which have the most invasive form of
mammalian placenta). It is reported rarely
in other great apes and absent in non-apes.
Parent-offspring conflict [4] may underlie
the evolutionary maintenance of pre-
eclampsia despite its burden of mortality.
Increased placental invasion and intimacy
of maternal–fetal contact is associated with
increased prenatal growth rates (but not
absolute size) of brain and body [5, 6].
Since mothers and offspring have different
optimal gestation lengths and growth
rates, there will be conflict over these
phenotypes. One additional benefit to the
fetus of invasive placentation is that the
metabolic costs of detoxifying harmful
byproducts of oxygen metabolism (i.e. oxi-
dative stress) can be offloaded onto the
mother by direct secretion of pro-inflam-
matory substances into her blood [7].
Consequently, alleles promoting or sup-
pressing invasion (of benefit to fetus and
mother, respectively) persist in the popula-
tion and may cause disease in certain gen-
etic combinations or maternal health
states. Conflict over placental invasion
may be exacerbated by high human pre-
natal brain growth rates which, along with
the unusually long human gestation length,
may explain pre-eclampsia’s high fre-
quency in humans but rarity in species with
less-demanding fetal brain growth
trajectories.
Humans have unusually low fecundabil-
ity, which promotes extended preconcep-
tion interaction between couples,
potentially reducing pre-eclampsia risk
through development of maternal toler-
ance of paternal antigens [3].
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FUTURE IMPLICATIONS
Genetic conflict should be expected in all
pregnancies and may lead to medical com-
plications. It may be of psychological benefit
for expectant parents to anticipate conflict
and its potential consequences from the be-
ginning of pregnancy, instead of viewing
pregnancy as maternal–fetal harmony.
Many mammals exhibit drastically
reduced placental invasion in normal preg-
nancy. Understanding how these species
combine low placental invasion with fetal
and maternal wellbeing, and how evolu-
tionary transitions between placental types
have occurred [7], may contribute to our
knowledge of human placental disorders.
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